In addition to functional impairments, CD8+ T cells exhibited significant metabolic changes during tumor evolution, with the most prominent being a marked downregulation of glycolytic activity during the advanced stage (Fig. 3D-E and Fig. S3C). Here, CD8A is linked to neoplasm.